New Product Watch

Premium

Genedata has launched Expressionist 5.3 with enhanced capabilities for transcriptomics-based biomarker discovery for applications in drug profiling and patient selection.

Specifically, Expressionist 5.3 expands the process capabilities of its Refiner Array module to support next-generation microarrays, including Affymetrix whole-transcript and exon arrays. For those using custom arrays, flexibility in pre-processing raw data has been increased by incorporating array type-specific layout information, Genedata said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.